<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="4266">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 18, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04753632</url>
  </required_header>
  <id_info>
    <org_study_id>DF0095UG</org_study_id>
    <nct_id>NCT04753632</nct_id>
  </id_info>
  <brief_title>Status of People With Cerebral Palsy and Their Caregivers During COVID-19 Pandemic</brief_title>
  <official_title>Assessment of the Biopsychosocial Status of People With Cerebral Palsy and Related Diseases and Their Caregivers During the COVID-19 Pandemic</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad de Granada</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidad de Granada</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      COVID-19, as well as the collateral situations that it entails, has been causing panic,&#xD;
      anguish and anxiety that has generated biopsychosocial problems in society affecting not only&#xD;
      the physical and social level but also the mental health and well-being.&#xD;
&#xD;
      The main objective of this research project is to assess the biopsychosocial status of people&#xD;
      with cerebral palsy and related diseases and their caregivers during the COVID-19 pandemic.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 15, 2021</start_date>
  <completion_date type="Anticipated">June 15, 2021</completion_date>
  <primary_completion_date type="Anticipated">May 15, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Questionnaire of Knowledge, attitudes and practice towards COVID-19</measure>
    <time_frame>Baseline</time_frame>
    <description>Questionnaire to evaluate the knowledge about COVID</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Caregiver COVID-19 limitation scale</measure>
    <time_frame>Baseline</time_frame>
    <description>o examine the impact of the COVID-19 pandemic on caregivers</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Fear of Coronavirus-19 Scale</measure>
    <time_frame>Baseline</time_frame>
    <description>: It is a questionnaire that assesses the fear of COVID-19. It consists of 7 items scored on a 5-item Likert scale. The higher the score, the more fear</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Covid-19 Stress Scale (CSS)</measure>
    <time_frame>Baseline</time_frame>
    <description>COVID stress scale (CSS): is a 36-item COVID Stress Scale (CSS) to measure these features, as they pertain to COVID-19. The CSS were developed to better understand and assess COVID-19-related distress. The scales were intentionally designed so they could be readily adapted for future pandemics.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Coronavirus Anxiety Scale</measure>
    <time_frame>Baseline</time_frame>
    <description>Coronavirus anxiety scale (CAS): It is a scale that measures the anxiety generated by COVID-19 in the last two weeks.&#xD;
It presents 5 items and a score&gt; 9 indicates dysfunctional anxiety associated with the pandemic.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Connor-Davidson Resilience Scale-10</measure>
    <time_frame>Baseline</time_frame>
    <description>Connor-Davidson Resilience Scale (CD-RISC) was used to measure resilience. The original English scale consists of 25 items which form five factors. Respondents are asked to answer on a five-point Likert scale (0 = totally disagree to 4 = totally agree)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Intolerance of Uncertainty Scale-12</measure>
    <time_frame>Baseline</time_frame>
    <description>The Intolerance of Uncertainty Scale-12 (IUS-12) The IUS-12 is a 12-item self-report questionnaire where items are rated on 5-point Likert scales. The IUS-12 demonstrated good psychometric properties in community and treatment-seeking samples</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Impact of Event Scale</measure>
    <time_frame>Baseline</time_frame>
    <description>The Impact of Event Scale (IES) is a short set of 15 questions that can measure the amount of distress that you associate with a specific event.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>COPE</measure>
    <time_frame>Baseline</time_frame>
    <description>The Brief-COPE is a 28 item self-report questionnaire designed to measure effective and ineffective ways to cope with a stressful life event. &quot;Coping&quot; is defined broadly as an effort used to minimize distress associated with negative life experiences</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Family Empowerment Scale</measure>
    <time_frame>Baseline</time_frame>
    <description>The Family Empowerment Scale (FES), a 34-item rating scale, was developed to measure empowerment in families with children who have emotional, behavioral, or mental disorders.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Medical Outcomes Study-Social Support Survey</measure>
    <time_frame>Baseline</time_frame>
    <description>This brief, self-administered Social Support Survey instrument was developed for patients in the Medical Outcomes Study (MOS), a two-year study of patients with chronic conditions.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Euroqol-5D</measure>
    <time_frame>Baseline</time_frame>
    <description>The perception of the level of health and the quality of life were evaluated with the questionnaire European Quality of&#xD;
Life-5 Dimensions (EQ-5D). It is composed of 2 parts in which health status is assessed:&#xD;
Descriptive system: It consists on 5 dimensions that include mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Patients classify their health status in 3 severity levels: having no problems, having some or moderate problems, being unable to do/having extreme problems. Visual Analog Scale, by which respondents can report their perceived health status with a grade ranging from 0 (the worst possible health status) to 100 (the best possible health status)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PERMA-Profile</measure>
    <time_frame>Baseline</time_frame>
    <description>5 pillars of well-being that he calls PERMA - positive emotion, engagement, relationships, meaning, and accomplishment. The PERMA-Profiler measures these five pillars, along with negative emotion and health.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Anxiety and Depression Scale</measure>
    <time_frame>Baseline</time_frame>
    <description>Anxiety and depression will be assessed with the Hospital Anxiety and Depression Scale (HADS) . This scale is composed of 14 items divided into two subscales, 7 items of anxiety and 7 items of depression, involving higher values worse psycho-emotional state.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pittsburgh Sleep Quality Index</measure>
    <time_frame>Baseline</time_frame>
    <description>The Pittsburgh Sleep Quality Index (PSQI) is a self-rated questionnaire which assesses sleep quality and disturbances over a 1-month time interval.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>International Physical Activity Questionnaire</measure>
    <time_frame>Baseline</time_frame>
    <description>The International Physical Activity Questionnaire (IPAQ) was developed to measure health-related physical activity (PA) in populations.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional independence measure</measure>
    <time_frame>Baseline</time_frame>
    <description>The Functional Independence Measure (FIM) is an 18-item measurement tool that explores an individual's physical, psychological and social function.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gross motor function classification system</measure>
    <time_frame>Baseline</time_frame>
    <description>The GMFCS, or Gross Motor Function Classification System, is a five-level classification that differentiates children with cerebral palsy based on the child's current gross motor abilities, limitations in gross motor function, and need for assistive technology and wheeled mobility.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Manual Agility Classification System</measure>
    <time_frame>Baseline</time_frame>
    <description>The Manual Ability Classification System (MACS) describes how children with cerebral palsy use their hands to handle objects in daily activities. MACS describes five levels.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Cerebral Palsy</condition>
  <arm_group>
    <arm_group_label>Cerebral palsy patients and caregivers</arm_group_label>
    <description>Cerebral palsy patients and caregivers</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy people and their caregivers</arm_group_label>
    <description>Healthy people and their caregivers</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Cerebral palsy patients and their caregivers&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Cerebral palsy patients and their caregivers&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients or caregivers with Cognitive impairment&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 12, 2021</study_first_submitted>
  <study_first_submitted_qc>February 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 15, 2021</study_first_posted>
  <last_update_submitted>February 12, 2021</last_update_submitted>
  <last_update_submitted_qc>February 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidad de Granada</investigator_affiliation>
    <investigator_full_name>Marie Carmen Valenza</investigator_full_name>
    <investigator_title>Principal Investigator; PT; PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cerebral Palsy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

